Novel Therapeutic Strategies for Systemic Cardiovascular Disease
An Integrated Approach to Treating Heart Failure and Valve Disease, Vascular Disease and Stroke
Friday, March 8, 2013
5 pm - 8 pm
InterContinental San Francisco
888 Howard Street
San Francisco, California 94103
Novel Therapeutic Strategies for Systemic Cardiovascular Disease: An Integrated Approach to Treating Heart Failure and Valve Disease, Vascular Disease and Stroke presents evidence-based strategies that will impact your practice performance and improve outcomes for your patients with cardiovascular disease. The expert faculty will provide insights and opinions on methods for providing comprehensive diagnosis, treatment and management of patients while working in an integrated, multispecialty program.
5:00 pm Registration/Dinner
5:15 pm – 5:25 pm Welcome/Agenda Overview
5:25 pm – 5:50 pm Heart Valve Decision Making: The impact of the percutaneous option
5:50 pm – 6:00 pm Q&A
6:00 pm – 6:25 pm Emerging Therapies for Thoracic Aortic Disease: The link between medicine, surgery and endovascular technologies
6:25 pm – 6:35 pm Q&A
6:35 pm – 7:00 pm Pulmonary Embolism Response Team: The new, multidisciplinary approach to treatment
7:00 pm – 7:10 pm Q&A
7:10 pm – 7:35 pm Atrial Fibrillation and Stroke: Rapid evolution of treatment opportunities
7:35 pm – 7:50 pm Q&A
7:50 pm -8:00 pm Closing Remarks
This educational activity is not part of ACC.13; however, the content was reviewed and approved by the ACC.13 Program Committee.
CME/CEU Credits: Approved for 2.75 AMA PRA Category 1 Credit(s).
U.S. News & World Report ranks Mass General #1 in New England and #2 in the nation based on our quality of care, patient safety and reputation in 16 clinical specialties.
Search the archive for previously published news articles, press releases and publications.
Departments and Centers at Mass General have a reputation for excellence in patient care. View a list of all departments.